SCHEMBL4146592

SCHEMBL4146592

CCOC(=O)c1ccc2[nH]nc(/C=C/c3cccc(C(C)=O)c3)c2c1OC

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KDR P35968 5/20 0.37
TP53 P04637 3/20 0.37
AURKA O14965 2/20 0.37
AURKB Q96GD4 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
CHEK1 O14757 2/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
NPC1 O15118 1/20 0.36
TNFRSF1A P19438 1/20 0.36
ALOX15 P16050 1/20 0.35
FGFR1 P11362 1/20 0.35
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4146596 1.00 ALDH1A1 (0.38) ALDH1A1NPSR1KDRTP53AURKA
SCHEMBL4141145 0.89 ALDH1A1 (0.37) ALDH1A1KDRTP53AURKAAURKB
SCHEMBL4141139 0.89 ALDH1A1 (0.37) ALDH1A1KDRTP53AURKAAURKB
SCHEMBL4146169 0.88 KDR (0.42) KDRAURKAAURKBCHEK1TNFRSF1A
SCHEMBL4146162 0.88 KDR (0.42) KDRAURKAAURKBCHEK1TNFRSF1A
SCHEMBL5027604 0.84 NPC1 (0.36) ALDH1A1NPSR1TP53AURKAKDM4E
SCHEMBL5027600 0.84 NPC1 (0.36) ALDH1A1NPSR1TP53AURKAKDM4E
SCHEMBL4149953 0.84 CHEK1 (0.46) ALDH1A1NPSR1KDRKDM4EHPGD
SCHEMBL4149958 0.84 CHEK1 (0.46) ALDH1A1NPSR1KDRKDM4EHPGD
SCHEMBL4136174 0.83 NPC1 (0.38) ALDH1A1NPSR1AURKAKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054397-A1 PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND OHI NORIHITO 2009-02-26 US disclosed
US-20090054397-A1 PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND OHI NORIHITO 2009-02-26 US disclosed
US-20090054397-A1 PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND OHI NORIHITO 2009-02-26 US disclosed
US-7429609-B2 Pyrazole compound and medicinal composition containing the same EISAI R & D MANAGEMENT CO., LTD. (JP) 2008-09-30 US disclosed
US-7429609-B2 Pyrazole compound and medicinal composition containing the same EISAI R & D MANAGEMENT CO., LTD. (JP) 2008-09-30 US disclosed
US-7429609-B2 Pyrazole compound and medicinal composition containing the same EISAI R & D MANAGEMENT CO., LTD. (JP) 2008-09-30 US disclosed
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-24 US disclosed
US-20050208582-A1 Pyrazole compounds and pharmaceutical compositions comprising the compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-09-22 US disclosed
EP-1510516-A1 PYRAZOLE COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME Eisai Co., Ltd. (JP) 2005-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054397-A1 PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND CNKSR1, NR3C2, CSNK2B ALDH1A1 2731/4885NPSR1 1749/4885KDR 932/4885
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same CNKSR1, NR3C2, CSNK2B ALDH1A1 2713/4885NPSR1 2210/4885KDR 1044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.